Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Semaglutide is not intended for use in patients with type 1 diabetes or to treat diabetic [7] ketoacidosis
Weekly Injections Semaglutide has shown promising results in clinical trials for weight loss, with participants losing an average of 10% to 15% of their body weight over 16 to 72 weeks, depending on the dosage and individual factors
Routine monitoring of serum calcitonin or using thyroid ultrasound is of uncertain value for early detection of MTC in patients treated with TRULICITY [see Contraindications (4) and Warnings and Precautions (5.1)]
Some patients do better with a tiered plan
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
